Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR-T cells are as effective as freshly infused cells

被引：0
|
作者：
Dreyzin, Alexandra [1 ]
Panch, Sandhya [2 ]
Shalabi, Haneen [3 ]
Yates, Bonnie [3 ]
Shah, Nirali [3 ]
Stroncek, David [2 ]
机构：
[1] Childrens Natl Hosp, Ctr Canc & Blood Disorders, Washington, DC USA
[2] NIH, Dept Transfus Med & Cellular Engn, Ctr Cellular Engn, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
    Luo, Zhiqiang
    Shi, Jiaru
    Jiang, Qiyao
    Yu, Guohua
    Li, Xiaorui
    Yu, Zhuoying
    Wang, Jianxun
    Shi, Yuanyuan
    MOLECULAR BIOMEDICINE, 2023, 4 (01):
  • [32] Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
    Zhiqiang Luo
    Jiaru Shi
    Qiyao Jiang
    Guohua Yu
    Xiaorui Li
    Zhuoying Yu
    Jianxun Wang
    Yuanyuan Shi
    Molecular Biomedicine, 4
  • [33] Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
    Jin, Xuexiao
    Xu, Qin
    Pu, Chengfei
    Zhu, Kaixiang
    Lu, Cheng
    Jiang, Yu
    Xiao, Lei
    Han, Yongmei
    Lu, Linrong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (08) : 1896 - 1903
  • [34] Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells
    Beyar-Katz, Ofrat
    Kikozashvili, Nino
    Bar On, Yael
    Amit, Odelia
    Perry, Chava
    Avivi, Irit
    Gold, Ronit
    Herishanu, Yair
    Benyamini, Noam
    Duek, Adrian
    Ben-Ami, Ronen
    Shasha, David
    Ram, Ron
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 108 (01) : 52 - 60
  • [35] Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
    Xuexiao Jin
    Qin Xu
    Chengfei Pu
    Kaixiang Zhu
    Cheng Lu
    Yu Jiang
    Lei Xiao
    Yongmei Han
    Linrong Lu
    Cellular & Molecular Immunology, 2021, 18 : 1896 - 1903
  • [36] Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
    Su, Yi-Jiun
    Kramer, Anne Marijn
    Hamilton, Mark P.
    Agarwal, Neha
    Srinagesh, Hrishikesh K.
    Baird, John H.
    Sahaf, Bita
    Kuo, Adam
    Ehlinger, Zachary J.
    Desai, Moksha H.
    Rietberg, Skyler P.
    Tunuguntla, Ramya
    Patel, Shabnum
    Chinnasamy, Harshini
    Gkitsas-Long, Nikolaos
    Klysz, Dorota D.
    Brown, Annie Kathleen
    Bharadwaj, Sushma
    Dahiya, Saurabh
    Smith, Melody
    Muffly, Lori
    Mackall, Crystal L.
    Good, Zinaida
    Feldman, Steven A.
    Miklos, David B.
    Frank, Matthew J.
    CANCER DISCOVERY, 2025, 15 (04) : 733 - 747
  • [37] Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
    Martin-Martin, Lourdes
    Gutierrez-Herrero, Sara
    Herrero-Garcia, Maria
    Martin Garcia-Sancho, Alejandro
    Yeguas, Ana
    Martin-Lopez, Ana-africa
    Lopez-Corral, Lucia
    Perez-Lopez, Estefania
    Garcia-Blazquez, Marta
    Sanchez-Guijo, Fermin
    Vidriales, Maria Belen
    Gaipa, Giuseppe
    Orfao, Alberto
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [38] Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review
    Becerril-Rico, Jared
    Delgado-Montes, Yerenia A. A.
    Ortiz-Sanchez, Elizabeth
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1822 - 1831
  • [39] Anti-CD22 CAR Therapy Leads to ALL Remissions
    Rose, Suzanne
    CANCER DISCOVERY, 2017, 7 (02) : 120 - 120
  • [40] IMMUNOTHERAPY Treatment of aggressive lymphomas with anti-CD19 CAR T cells
    Klebanoff, Christopher A.
    Yamamoto, Tori N.
    Restifo, Nicholas P.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (12) : 685 - 686
12345